A novel magnetically controlled bioreactor for ex vivo expansion of NK-92 cells

• Published in: Bioresources and bioprocessing Vol. 9; no. 1; p. 50
• Main Authors: Liu, Yangyang, Sun, Qihao, Hao, Mengyang, Tan, Wen‑Song, Cai, Haibo
• Format: Journal Article
• Language: English
• Published: Singapore Springer Nature Singapore 03.05.2022; SpringerOpen
• Subjects: Biochemical Engineering; Bioreactor; Chemistry; Chemistry and Materials Science; Environmental Engineering/Biotechnology; Ex vivo expansion; Industrial and Production Engineering; Magnetic field; NK-92 cells; NK-92 cells; Ex vivo expansion; Bioreactor; Magnetic field
• ISSN: 2197-4365; 2197-4365
• DOI: 10.1186/s40643-022-00537-z

The application of natural killer (NK) cells as potential antitumor effector cells appears to be valuable for immunotherapies. However, the clinical use of NK cells is limited because the technical difficulties associated with mass production NK cells at sufficiently high numbers represents a great challenge. Ex vivo expansion of NK cells is a key technology for cell therapy. Bioreactor systems can generate homogeneous culture condition and modulate the environmental and biochemical cues. In this study, a novel magnetically controlled bioreactor was developed for supporting NK cells ex vivo expansion. Using synthetic magnetic beads, the stirring device of the magnetically controlled bioreactor generated reduced shearing force. The intermittent magnetic field was applied for magnetic beads movement to homogenize the culture system. NK-92 cells were cultured in the magnetically controlled bioreactor and the expansion and function of expanded cells were investigated on day 8. The results showed that the expansion of NK-92 cells in the bioreactor was 67.71 ± 10.60-fold, which was significantly higher than that of the T25 culture flask ( P  < 0.05). Moreover, the proportions of CD3 − CD56 + cells and cell killing activity of expanded cells in the bioreactor did not reveal any differences compared to T25 flasks. Taken together, this study demonstrated the possibility of magnetically controlled bioreactor as a potent strategy in NK cells production for facilitating cancer immunotherapy. Graphical Abstract